المؤلفون: Page EC; Oncogenetics Team, Institute of Cancer Research, London, UK., Bancroft EK; Oncogenetics Team, Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Brook MN; Oncogenetics Team, Institute of Cancer Research, London, UK., Assel M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY, USA., Hassan Al Battat M; Department of Translational Medicine, Lund University, Malmö, Sweden., Thomas S; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Taylor N; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Chamberlain A; Oncogenetics Team, Institute of Cancer Research, London, UK., Pope J; Oncogenetics Team, Institute of Cancer Research, London, UK., Raghallaigh HN; Oncogenetics Team, Institute of Cancer Research, London, UK., Evans DG; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Rothwell J; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Maehle L; Department of medical genetics, Oslo University Hospital, 0424 Oslo, Norway., Grindedal EM; Department of medical genetics, Oslo University Hospital, 0424 Oslo, Norway., James P; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Australia; Genetic Medicine, The Royal Melbourne Hospital, Parkville, VIC, Australia., Mascarenhas L; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., McKinley J; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Side L; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., Thomas T; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., van Asperen C; Leiden University Medical Center, Leiden, The Netherlands., Vasen H; The Foundation for the Detection of Hereditary Cancer, Leiden, The Netherlands., Kiemeney LA; Radboud University Medical Center, Nijmegen, The Netherlands., Ringelberg J; The Foundation for the Detection of Hereditary Cancer, Leiden, The Netherlands., Jensen TD; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark., Osther PJS; Department of Urology, Vejle Hospital, Vejle, Denmark., Helfand BT; John and Carol Walter Center for Urological Health, Division of Urology, NorthShore University HealthSystem, Evanston, IL, USA., Genova E; John and Carol Walter Center for Urological Health, Division of Urology, NorthShore University HealthSystem, Evanston, IL, USA., Oldenburg RA; Department of clinical genetics, Erasmus University Medical Center, Rotterdam, The Netherlands., Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland., Wokolorczyk D; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland., Ong KR; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK., Huber C; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK., Lam J; Department of Urology, Flinders Medical Centre, Bedford Park, SA, Australia., Taylor L; Department of Urology, Repatriation General Hospital, Daw Park, SA, Australia., Salinas M; Hereditary Cancer Program, ICO-IDIBELL (Bellvitge Biomedical Research Institute, Catalan Institute of Oncology), CIBERONC, Barcelona, Spain., Feliubadaló L; Hereditary Cancer Program, ICO-IDIBELL (Bellvitge Biomedical Research Institute, Catalan Institute of Oncology), CIBERONC, Barcelona, Spain., Oosterwijk JC; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Zelst-Stams W; Radboud University Medical Center, Nijmegen, The Netherlands., Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK., Rosario DJ; Royal Hallamshire Hospital, Sheffield, UK., Domchek S; Basser Research Center, University of Pennsylvania, Philadelphia, PA, USA., Powers J; Basser Research Center, University of Pennsylvania, Philadelphia, PA, USA., Buys S; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., O'Toole K; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Ausems MGEM; Division of Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Centre, Utrecht, The Netherlands., Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Rhiem K; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Izatt L; Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK., Tripathi V; Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK., Teixeira MR; Genetics Department and Research Center, Portuguese Oncology Institute (IPO Porto), Porto, Portugal; Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal., Cardoso M; Genetics Department and Research Center, Portuguese Oncology Institute (IPO Porto), Porto, Portugal., Foulkes WD; Cancer Research Program, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada; Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada., Aprikian A; Cancer Research Program, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada., van Randeraad H; The Foundation for the Detection of Hereditary Cancer, Leiden, The Netherlands., Davidson R; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK., Longmuir M; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK., Ruijs MWG; Netherlands Cancer Institute, Amsterdam, The Netherlands., Helderman van den Enden ATJM; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands., Adank M; VU University Medical Center, Amsterdam, The Netherlands., Williams R; Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, NSW, Australia; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., Andrews L; Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, NSW, Australia; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., Murphy DG; The Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Halliday D; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK., Walker L; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK., Liljegren A; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden., Carlsson S; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden., Azzabi A; Northern Genetics Service, Newcastle upon Tyne Hospitals, UK., Jobson I; Northern Genetics Service, Newcastle upon Tyne Hospitals, UK., Morton C; Familial Cancer Centre, The Royal Melbourne Hospital, Grattan St, Parkville, VIC, Australia., Shackleton K; Familial Cancer Centre, The Royal Melbourne Hospital, Grattan St, Parkville, VIC, Australia., Snape K; St George's Hospital, Tooting, London, UK., Hanson H; St George's Hospital, Tooting, London, UK., Harris M; Familial Cancer Centre, Monash Health, Clayton, VIC, Australia., Tischkowitz M; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK; Academic Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Taylor A; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK., Kirk J; Familial Cancer Service, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Westmead, Sydney, NSW, Australia., Susman R; Genetic Health Queensland, Royal Brisbane & Women's Hospital, Herston, QLD, Australia., Chen-Shtoyerman R; The Genetic Institute, Kaplan Medical Center, Rehovot, Israel., Spigelman A; Hunter Family Cancer Service, Waratah, NSW, Australia; University of New South Wales, St Vincent's Clinical School, NSW, Australia; Cancer Genetics Clinic, The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia., Pachter N; Genetic Services of WA, King Edward Memorial Hospital, Subiaco, WA, Australia; Department of Paediatrics, University of Western Australia, Perth, WA, Australia., Ahmed M; NE Thames Regional Genetics Service, Institute of Child Health, London, UK., Ramon Y Cajal T; Hospital de Sant Pau, Barcelona, Spain., Zgajnar J; Institute of Oncology, Ljubljana, Slovenia., Brewer C; Peninsular Genetics, Derriford Hospital, Plymouth, UK; Royal Devon and Exeter Hospital, Exeter, UK., Gadea N; Hospital Vall d'Hebron, Barcelona, Spain., Brady AF; North West Thames Regional Genetics Service, Kennedy-Galton Centre, London North West University Healthcare NHS Trust, Harrow, UK., van Os T; Academic Medical Center, Amsterdam, The Netherlands., Gallagher D; St James's Hospital, Dublin, Ireland., Johannsson O; Landspitali-the National University Hospital of Iceland, Reykjavik, Iceland., Donaldson A; St Michael's Hospital, Bristol, UK., Barwell J; University of Leicester, Leicester, UK; University Hospitals Leicester, Leicester, UK., Nicolai N; Istituto Nazionale dei Tumori, Milano, Italy., Friedman E; Chaim Shema Medical Center, Tel-Hashomer, Israel., Obeid E; Fox Chase Cancer Center, Philadelphia, PA, USA., Greenhalgh L; Clinical Genetics Service, Liverpool Women's Hospital, Liverpool, UK., Murthy V; Tata Memorial Centre, Mumbai, India., Copakova L; National Cancer Institute, Bratislava, Slovak Republic., Saya S; Oncogenetics Team, Institute of Cancer Research, London, UK., McGrath J; Royal Devon and Exeter Hospital, Exeter, UK; University of Exeter Medical School, St Luke's Campus, Exeter, UK., Cooke P; New Cross Hospital, Wolverhampton, UK., Rønlund K; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark., Richardson K; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Henderson A; Northern Genetics Service, Newcastle upon Tyne Hospitals, UK; West Cumberland Infirmary, Whitehaven, UK., Teo SH; Cancer Research Initiatives Foundation, Subang Jaya Medical Centre, Selangor, Darul Ehsan, Malaysia., Arun B; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Kast K; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Dias A; Oncogenetics Team, Institute of Cancer Research, London, UK; Instituto Nacional de Cancer Jose de Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil., Aaronson NK; Netherlands Cancer Institute, Amsterdam, The Netherlands., Ardern-Jones A; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Bangma CH; Department of urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Castro E; Spanish National Cancer Research Center, Madrid, Spain., Dearnaley D; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, UK., Eccles DM; The University of Southampton Medical School, Southampton, UK; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., Tricker K; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Eyfjord J; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland., Falconer A; Imperial College Healthcare NHS Trust, London, UK., Foster C; HCA Pathology Laboratories, London, UK., Gronberg H; University Hospital, Umea, Sweden., Hamdy FC; Churchill Hospital, Headington, Oxford, UK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Stefansdottir V; Landspitali-the National University Hospital of Iceland, Reykjavik, Iceland., Khoo V; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; St George's Hospital, Tooting, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, UK; Department of Medicine, The University of Melbourne, Parkville, VIC, Australia., Lindeman GJ; Familial Cancer Centre, The Royal Melbourne Hospital, Grattan St, Parkville, VIC, Australia; Department of Medicine, The University of Melbourne, Parkville, VIC, Australia; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland., Axcrona K; Department of Urology, Akershus University Hospital, Lørenskog, Norway., Mikropoulos C; Medway Hospital, Kent, UK., Mitra A; University College London Hospitals NHS Foundation Trust, London, UK., Moynihan C; Oncogenetics Team, Institute of Cancer Research, London, UK., Rennert G; CHS National Cancer Control Center, Carmel Medical Center, Haifa, Israel., Suri M; Nottingham City Hospital, Nottingham, UK., Wilson P; Innovate UK, Polaris House, Swindon, UK., Dudderidge T; University Hospital Southampton, Southampton, UK., Offman J; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, Guy's Cancer Centre, Guy's Hospital, London, UK., Kote-Jarai Z; Oncogenetics Team, Institute of Cancer Research, London, UK., Vickers A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY, USA., Lilja H; Department of Translational Medicine, Lund University, Malmö, Sweden; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Departments of Laboratory Medicine, Surgery, and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Eeles RA; Oncogenetics Team, Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: rosalind.eeles@icr.ac.uk.

مؤلفون مشاركون: IMPACT Study Collaborators

المصدر: European urology [Eur Urol] 2019 Dec; Vol. 76 (6), pp. 831-842. Date of Electronic Publication: 2019 Sep 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA1* , Genes, BRCA2* , Germ-Line Mutation*, Early Detection of Cancer/*methods , Genetic Carrier Screening/*methods , Prostatic Neoplasms/*diagnosis , Prostatic Neoplasms/*genetics, Adult ; Aged ; Humans ; Kallikreins/blood ; Male ; Middle Aged ; Prospective Studies ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood

المؤلفون: Zakrzewski F; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Schubertstraße 15, 01307, Dresden, Germany. Falk.Zakrzewski@uniklinikum-dresden.de., Gieldon L; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Schubertstraße 15, 01307, Dresden, Germany.; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Rump A; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Seifert M; Institute for Medical Informatics and Biometry (IMB), Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany., Grützmann K; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Schubertstraße 15, 01307, Dresden, Germany., Krüger A; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Schubertstraße 15, 01307, Dresden, Germany., Loos S; Institute of Pathology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany., Zeugner S; Institute of Pathology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany., Hackmann K; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Porrmann J; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Wagner J; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Kast K; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany., Wimberger P; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany., Baretton G; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Schubertstraße 15, 01307, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; Institute of Pathology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Tumor- and Normal Tissue Bank of the University Cancer Center (UCC), University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, National Center for Tumor Diseases (NCT) Dresden, Dresden, Germany., Schröck E; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Schubertstraße 15, 01307, Dresden, Germany.; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany., Aust D; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Schubertstraße 15, 01307, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; Institute of Pathology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Tumor- and Normal Tissue Bank of the University Cancer Center (UCC), University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, National Center for Tumor Diseases (NCT) Dresden, Dresden, Germany., Klink B; Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT), Schubertstraße 15, 01307, Dresden, Germany.; Institute for Clinical Genetics, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.

المصدر: BMC cancer [BMC Cancer] 2019 Apr 27; Vol. 19 (1), pp. 396. Date of Electronic Publication: 2019 Apr 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer

مواضيع طبية MeSH: Germ-Line Mutation*, BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Breast Neoplasms/*genetics , High-Throughput Nucleotide Sequencing/*methods , Ovarian Neoplasms/*genetics, Breast Neoplasms/blood ; Breast Neoplasms/diagnosis ; DNA Copy Number Variations/genetics ; Female ; Formaldehyde/chemistry ; Humans ; INDEL Mutation ; Male ; Multiplex Polymerase Chain Reaction/methods ; Ovarian Neoplasms/blood ; Ovarian Neoplasms/diagnosis ; Paraffin Embedding ; Pedigree ; Reproducibility of Results ; Tissue Fixation

المؤلفون: Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Rhiem K; Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Strasse 34, 50931, Cologne, Germany., Hahnen E; Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Strasse 34, 50931, Cologne, Germany., Loibl S; German Breast Group, Neu-Isenburg, Germany.; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany., Weber KE; German Breast Group, Neu-Isenburg, Germany., Seiler S; German Breast Group, Neu-Isenburg, Germany., Zachariae S; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Hauke J; Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Strasse 34, 50931, Cologne, Germany., Wappenschmidt B; Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Strasse 34, 50931, Cologne, Germany., Waha A; Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Strasse 34, 50931, Cologne, Germany., Blümcke B; Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Strasse 34, 50931, Cologne, Germany., Kiechle M; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany., Meindl A; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany., Niederacher D; Department of Gynecology and Obstetrics, University Hospital of the Heinrich-Heine University, Düsseldorf, Germany., Bartram CR; Institute of Human Genetics, University Hospital, University of Heidelberg, Heidelberg, Germany., Speiser D; Zentrum für Familiären Brust- und Eierstockkrebs, Klinik für Gynäkologie mit Brustzentrum, Charité - Universitätsmedizin Berlin, Berlin, Germany., Schlegelberger B; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Arnold N; Institute of Clinical Molecular Biology/Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Wieacker P; Institute of Human Genetics, University Hospital Münster, Münster, Germany., Leinert E; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Gehrig A; Institute of Human Genetics, University Würzburg, Würzburg, Germany., Briest S; Center for Hereditary Breast and Ovarian Cancer, University Hospital Leipzig, Leipzig, Germany., Kast K; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Riess O; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany., Emons G; Klinik für Gynäkologie und Geburtshilfe, Universitätsmedizin, Göttingen, Germany., Weber BHF; Institute of Human Genetics, University of Regensburg, Regensburg, Germany., Engel J; Munich Cancer Registry (MCR) of the Munich Tumour Centre (TZM), Institute for Medical Information Processing, Biometry and Epidemiology (IBE), University Hospital of Munich, Ludwig-Maximilians-University (LMU), Munich, Germany., Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Strasse 34, 50931, Cologne, Germany. rita.schmutzler@uk-koeln.de.

مؤلفون مشاركون: German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC)

المصدر: BMC cancer [BMC Cancer] 2018 Mar 07; Vol. 18 (1), pp. 265. Date of Electronic Publication: 2018 Mar 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Testing* , Germ-Line Mutation*, BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Biomarkers, Tumor/*genetics , Triple Negative Breast Neoplasms/*genetics , Unilateral Breast Neoplasms/*genetics, Adult ; Aged ; Female ; Follow-Up Studies ; Germany/epidemiology ; Humans ; Middle Aged ; Prevalence ; Prognosis ; Triple Negative Breast Neoplasms/epidemiology ; Triple Negative Breast Neoplasms/pathology ; Unilateral Breast Neoplasms/epidemiology ; Unilateral Breast Neoplasms/pathology ; Young Adult

المؤلفون: Harter P; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Hauke J; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., Heitz F; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Reuss A; Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany., Kommoss S; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Marmé F; National Center for Tumor Disease/Department of Gynecology, University of Heidelberg, Heidelberg, Germany., Heimbach A; Institute of Human Genetics, University of Bonn, Bonn, Germany., Prieske K; Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Richters L; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., Burges A; Department of Gynecology, University Hospital Munich-Großhadern. Munich, Germany., Neidhardt G; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., de Gregorio N; Department of Gynecology, University of Ulm, Ulm, Germany., El-Balat A; Department of Gynecology, University of Frankfurt, Frankfurt, Germany., Hilpert F; Onkologisches Therapiezentrum, Krankenhaus Jerusalem, Hamburg, Germany/ Department of Gynecology, University of Kiel, Kiel, Germany.; Department of Gynecology, University of Kiel, Kiel, Germany., Meier W; Department of Gynecology, Evangelisches Krankenhaus, Duesseldorf, Germany., Kimmig R; Department of Gynecology, University of Essen, Essen, Germany., Kast K; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany., Sehouli J; Department of Gynecology and Gynecological Oncology, Charité, Campus Virchow, Berlin, Germany., Baumann K; Department of Gynecology and Obstetrics, Klinikum Ludwigshafen, Ludwigshafen, Germany.; Department of Gynecology, Gynecologic Endocrinology & Oncology, Philipps-University Marburg, Marburg, Germany., Jackisch C; Department of Gynecology and Obstetrics, Sana Klinikum, Offenbach, Germany., Park-Simon TW; Department of Gynecology, Medizinische Hochschule Hannover, Hannover, Germany., Hanker L; Department of Gynecology & Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Kröber S; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., Pfisterer J; Center of Gynecological Oncology, Kiel, Germany., Gevensleben H; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Schnelzer A; Department of Gynecology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Dietrich D; University Hospital Bonn, Department of Otolaryngology, Head and Neck Surgery, Bonn, Germany., Neunhöffer T; Department of Gynecology, Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany., Krockenberger M; Department of Gynecology, University of Würzburg, Würzburg, Germany., Brucker SY; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Nürnberg P; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany., Thiele H; Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany., Altmüller J; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany., Lamla J; AGO Study Group, Wiesbaden, Germany., Elser G; AGO Study Group, Wiesbaden, Germany., du Bois A; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Hahnen E; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., Schmutzler R; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany.

المصدر: PloS one [PLoS One] 2017 Oct 20; Vol. 12 (10), pp. e0186043. Date of Electronic Publication: 2017 Oct 20 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA1* , Genes, BRCA2* , Genetic Predisposition to Disease* , Germ-Line Mutation*, Ovarian Neoplasms/*genetics, Female ; Humans

المؤلفون: Kast K; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany., Rhiem K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Wappenschmidt B; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Hahnen E; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Hauke J; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Bluemcke B; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Zarghooni V; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Herold N; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Ditsch N; Department for Gynecology and Obstetrics, LMU Munich, Munich, Germany., Kiechle M; Department for Gynecology and Obstetrics, Technical University of Munich, Munich, Germany., Braun M; Breast Center, Department of Gynecology, Red Cross Hospital, Munich, Germany., Fischer C; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Dikow N; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Schott S; Department of Gynecology and Obstetrics, Heidelberg University Hospital, Heidelberg, Germany German Cancer Consortium (DKTK), NCT Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Rahner N; Medical Faculty, Institute of Human Genetics and Anthropology, Heinrich-Heine University, Düsseldorf, Germany., Niederacher D; Department of Gynecology and Obstetrics, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany., Fehm T; Department of Gynecology and Obstetrics, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany., Gehrig A; Department of Human Genetics, University of Wuerzburg, Würzburg, Germany., Mueller-Reible C; Department of Human Genetics, University of Wuerzburg, Würzburg, Germany., Arnold N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Maass N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Borck G; Institute of Human Genetics, University of Ulm, Ulm, Germany., de Gregorio N; Department of Gynecology and Obstetrics, University Hospital, Universität Ulm, Ulm, Germany., Scholz C; Institute of Human Genetics, Hannover Medical School, Hannover, Germany., Auber B; Institute of Human Genetics, Hannover Medical School, Hannover, Germany., Varon-Manteeva R; Institute of Medical and Human Genetics, Charite-University Medical Center, Berlin, Germany., Speiser D; Department of Gynecology, Charité University Medicine Berlin, Berlin, Germany., Horvath J; Institute for Human Genetics, University of Muenster, Münster, Germany., Lichey N; Institute for Human Genetics, University of Muenster, Münster, Germany., Wimberger P; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany., Stark S; Department of Gynecology and Obstetrics, University of Leipzig, Leipzig, Germany., Faust U; Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tübingen, Germany., Weber BH; Institute of Human Genetics, University of Regensburg, Regensburg, Germany., Emons G; Department of Obstetrics and Gynecology, University of Göttingen, Göttingen, Germany., Zachariae S; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Meindl A; Department for Gynecology and Obstetrics, Technical University of Munich, Munich, Germany., Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

مؤلفون مشاركون: German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC)

المصدر: Journal of medical genetics [J Med Genet] 2016 Jul; Vol. 53 (7), pp. 465-71. Date of Electronic Publication: 2016 Feb 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-6244 (Electronic) Linking ISSN: 00222593 NLM ISO Abbreviation: J Med Genet Subsets: MEDLINE

مواضيع طبية MeSH: BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Breast Neoplasms/*genetics , Breast Neoplasms, Male/*genetics , Germ-Line Mutation/*genetics , Ovarian Neoplasms/*genetics, Adult ; Female ; Genetic Predisposition to Disease/genetics ; Genetic Testing/methods ; Humans ; Male ; Middle Aged ; Prevalence

المؤلفون: Ramus SJ; Department of Gynaecological Oncology, UCL EGA Institute for Women's Health, University College London, London, UK. sramus@usc.edu, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Allavena A, Ottini L, Papi L, Gismondi V, Capra F, Radice P, Greene MH, Mai PL, Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Gerdes AM, Kruse TA, Cruger D, Jensen UB, Caligo MA, Olsson H, Kristoffersson U, Lindblom A, Arver B, Karlsson P, Stenmark Askmalm M, Borg A, Neuhausen SL, Ding YC, Nathanson KL, Domchek SM, Jakubowska A, Lubiński J, Huzarski T, Byrski T, Gronwald J, Górski B, Cybulski C, Dębniak T, Osorio A, Durán M, Tejada MI, Benítez J, Hamann U, Rookus MA, Verhoef S, Tilanus-Linthorst MA, Vreeswijk MP, Bodmer D, Ausems MG, van Os TA, Asperen CJ, Blok MJ, Meijers-Heijboer HE, Peock S, Cook M, Oliver C, Frost D, Dunning AM, Evans DG, Eeles R, Pichert G, Cole T, Hodgson S, Brewer C, Morrison PJ, Porteous M, Kennedy MJ, Rogers MT, Side LE, Donaldson A, Gregory H, Godwin A, Stoppa-Lyonnet D, Moncoutier V, Castera L, Mazoyer S, Barjhoux L, Bonadona V, Leroux D, Faivre L, Lidereau R, Nogues C, Bignon YJ, Prieur F, Collonge-Rame MA, Venat-Bouvet L, Fert-Ferrer S, Miron A, Buys SS, Hopper JL, Daly MB, John EM, Terry MB, Goldgar D, Hansen Tv, Jønson L, Ejlertsen B, Agnarsson BA, Offit K, Kirchhoff T, Vijai J, Dutra-Clarke AV, Przybylo JA, Montagna M, Casella C, Imyanitov EN, Janavicius R, Blanco I, Lázaro C, Moysich KB, Karlan BY, Gross J, Beattie MS, Schmutzler R, Wappenschmidt B, Meindl A, Ruehl I, Fiebig B, Sutter C, Arnold N, Deissler H, Varon-Mateeva R, Kast K, Niederacher D, Gadzicki D, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Simard J, Soucy P, Spurdle AB, Holland H, Chenevix-Trench G, Easton DF, Antoniou AC

مؤلفون مشاركون: OCGN, HEBON, EMBRACE, GEMO Study Collaborators, BCFR, kConFab Investigators, Consortium of Investigators of Modifiers of BRCA1/2

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2011 Jan 19; Vol. 103 (2), pp. 105-16. Date of Electronic Publication: 2010 Dec 17.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA1* , Genes, BRCA2* , Germ-Line Mutation* , Heterozygote* , Polymorphism, Single Nucleotide*, Chromosomes, Human, Pair 9/*genetics , Ovarian Neoplasms/*genetics, Adult ; Aged ; Aged, 80 and over ; Alleles ; Female ; Genotype ; Humans ; Likelihood Functions ; Middle Aged ; Odds Ratio ; Retrospective Studies ; Risk Factors

المؤلفون: Meindl A; Department of Obstetrics and Gynecology, Division of Tumor Genetics, Klinikum rechts der Isar der Technischen Universitaet Muenchen, Munich, Germany. alfons.meindl@lrz.tu-muenchen.de, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Müller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H

المصدر: Nature genetics [Nat Genet] 2010 May; Vol. 42 (5), pp. 410-4. Date of Electronic Publication: 2010 Apr 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease* , Germ-Line Mutation*, Breast Neoplasms/*genetics , Ovarian Neoplasms/*genetics, Alleles ; Case-Control Studies ; DNA-Binding Proteins/genetics ; Fanconi Anemia/genetics ; Female ; Germany ; Humans ; Models, Genetic ; Mutation ; Pedigree ; Phenotype

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Mavaddat, N., Barrowdale, D., Andrulis, I.L., Domchek, S.M., Eccles, D., Nevanlinna, H., Ramus, S.J., Spurdle, A., Robson, M., Sherman, M., Mulligan, A.M., Couch, F.J., Engel, C., McGuffog, L., Healey, S., Sinilnikova, O.M., Southey, M.C., Terry, M.B., Goldgar, D., O'Malley, F., John, E.M., Janavicius, R., Tihomirova, L., Hansen, T.V.O., Nielsen, F.C., Osorio, A., Stavropoulou, A., Benitez, J., Manoukian, S., Peissel, B., Barile, M., Volorio, S., Pasini, B., Dolcetti, R., Putignano, A.L., Ottini, L., Radice, P., Hamann, U., Rashid, M.U., Hogervorst, F.B., Kriege, M., Luijt, R.B. van der, Peock, S., Frost, D., Evans, D.G., Brewer, C., Walker, L., Rogers, M.T., Side, L.E., Houghton, C., Weaver, J., Godwin, A.K., Schmutzler, R.K., Wappenschmidt, B., Meindl, A., Kast, K., Arnold, N., Niederacher, D., Sutter, C., Deissler, H., Gadzicki, D., Preisler-Adams, S., Varon-Mateeva, R., Schonbuchner, I., Gevensleben, H., Stoppa-Lyonnet, D., Belotti, M., Barjhoux, L., Isaacs, C., Peshkin, B.N., Caldes, T., Hoya, M. de la, Canadas, C., Heikkinen, T., Heikkila, P., Aittomaki, K., Blanco, I., Lazaro, C., Brunet, J., Agnarsson, B.A., Arason, A., Barkardottir, R.B., Dumont, M., Simard, J., Montagna, M., Agata, S., D'Andrea, E., Yan, M., Fox, S., Rebbeck, T.R., Rubinstein, W., Tung, N., Garber, J.E., Wang, X.S., Fredericksen, Z., Pankratz, V.S., Lindor, N.M., Szabo, C., Offit, K., Sakr, R., Gaudet, M.M., Singer, C.F., Tea, M.K., Rappaport, C., Mai, P.L., Greene, M.H., Sokolenko, A., Imyanitov, E., Toland, A.E., Senter, L., Sweet, K., Thomassen, M., Gerdes, A.M., Kruse, T., Caligo, M., Aretini, P., Rantala, J., Wachenfeld, A. von, Henriksson, K., Steele, L., Neuhausen, S.L., Nussbaum, R., Beattie, M., Odunsi, K., Sucheston, L., Gayther, S.A., Nathanson, K., Gross, J., Walsh, C., Karlan, B., Chenevix-Trench, G., Easton, D.F., Antoniou, A.C., HEBON, EMBRACE, GEMO Study Collaborators, kConFab Investigators, SWE-BRCA Collaborators, Consortium Investigators Modifiers

المساهمون: Medical Oncology, Clinical Genetics, MUMC+: DA KG Lab Centraal Lab (9), Genetica & Celbiologie, RS: GROW - School for Oncology and Reproduction

المصدر: Cancer Epidemiology Biomarkers & Prevention; Vol 21
Cancer Epidemiology Biomarkers & Prevention, 21(1), 134-147. American Association for Cancer Research Inc.
Cancer Epidemiology, Biomarkers & Prevention, 21, 1, pp. 134-47
Cancer Epidemiology, Biomarkers and Prevention, 21(1), 134-147
Cancer Epidemiology, Biomarkers & Prevention, 21, 134-47
Mavaddat, N, Barrowdale, D, Andrulis, I L, Domchek, S M, Eccles, D, Nevanlinna, H, Ramus, S J, Spurdle, A, Robson, M, Sherman, M, Mulligan, A M, Couch, F J, Engel, C, McGuffog, L, Healey, S, Sinilnikova, O M, Southey, M C, Terry, M B, Goldgar, D, O'Malley, F, John, E M, Janavicius, R, Tihomirova, L, Hansen, T V O, Nielsen, F C, Osorio, A, Stavropoulou, A, Benítez, J, Manoukian, S, Peissel, B, Barile, M, Volorio, S, Pasini, B, Dolcetti, R, Putignano, A L, Ottini, L, Radice, P, Hamann, U, Rashid, M U, Hogervorst, F B, Kriege, M, van der Luijt, R B, Peock, S, Frost, D, Evans, D G, Brewer, C, Walker, L, Thomassen, M, Gerdes, A-M, Kruse, T & for HEBON 2011, ' Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) ', Cancer Epidemiology, Biomarkers & Prevention, vol. 21, no. 1, pp. 134-47 . https://doi.org/10.1158/1055-9965.EPI-11-0775

مصطلحات موضوعية: Oncology, Pathology, endocrine system diseases, Epidemiology, Genes, BRCA2, Genes, BRCA1, Estrogen receptor, Gene mutation, 0302 clinical medicine, Cancer screening, Medicine, skin and connective tissue diseases, Estrogen Receptor Status, Ovarian Neoplasms, 0303 health sciences, Middle Aged, female genital diseases and pregnancy complications, 3. Good health, Serous fluid, triple-negative tumors, 030220 oncology & carcinogenesis, Female, estrogen receptor, Adult, medicine.medical_specialty, BRCA1, BRCA2, breast cancer, Hereditary cancer and cancer-related syndromes Genetics and epigenetic pathways of disease [ONCOL 1], Breast Neoplasms, Article, 03 medical and health sciences, Breast cancer, SDG 3 - Good Health and Well-being, Translational research [ONCOL 3], Internal medicine, Humans, Genetic Predisposition to Disease, Genetics and epigenetic pathways of disease Translational research [NCMLS 6], Germ-Line Mutation, Aged, 030304 developmental biology, Hereditary cancer and cancer-related syndromes [ONCOL 1], business.industry, Cancer, medicine.disease, Neoplasm Grading, business, Ovarian cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05310148e4e4486e517e1140cc99edc0
https://hdl.handle.net/1887/97446

المؤلفون: Thomas v O Hansen, Amanda B. Spurdle, Anne-Marie Gerdes, Sue Healey, Per Karlsson, Tomasz Huzarski, Mary B. Daly, Mary Porteous, T. Caldes, Ulf Kristoffersson, Ignacio Blanco, A. Miron, Laurence Faivre, Barbara Wappenschmidt, Laurence Venat-Bouvet, Marie Stenmark Askmalm, Olga M. Sinilnikova, Susan Peock, Alessandra Viel, Conxi Lázaro, Katherine L. Nathanson, Laurent Castera, Douglas F. Easton, Susan L. Neuhausen, Jan Lubinski, Phuong L. Mai, Virginie Moncoutier, Paolo Radice, Heli Nevanlinna, Christi J Asperen, Xianshu Wang, Brita Arver, Christian Sutter, Senno Verhoef, Rosette Lidereau, Mary S Beattie, Bjarni A Agnarsson, Ina Ruehl, Monica Barile, Bent Ejlertsen, Laura Ottini, Catherine Noguès, Jennifer A. Przybylo, Cinzia Casella, Trevor Cole, Norbert Arnold, Sandra Fert-Ferrer, Hilmi Ozcelik, Irene L. Andrulis, Susan M. Domchek, Valérie Bonadona, Kirsten B. Moysich, David E. Goldgar, Anna Jakubowska, Paul D.P. Pharoah, Beth Y. Karlan, Jenny Gross, Gaia Roversi, Tadeusz Dębniak, Hanne Meijers-Heijboer, Susan J. Ramus, Dorthe G. Crüger, Zachary S. Fredericksen, Siranoush Manoukian, Viviana Gismondi, Maria A. Caligo, Helene Holland, Laure Barjhoux, Gord Glendon, Ana Osorio, Jacques Simard, John L. Hopper, Mercedes Durán, Kristiina Aittomäki, Håkan Olsson, Mads Thomassen, Fabio Capra, Patrick J. Morrison, Britta Fiebig, Mary Beth Terry, Marinus J. Blok, Evgeny N. Imyanitov, Joseph Vijai, Javier Benitez, Mark T. Rogers, D. Gareth Evans, Helmut Deissler, Tomasz Byrski, Sylvie Mazoyer, Laura Papi, Dominique Stoppa-Lyonnet, Marco Montagna, Kenneth Offit, Cezary Cybulski, Dominique Leroux, Georgia Chenevix-Trench, Danielle Bodmer, Lucy Side, Margaret Cook, Ros Eeles, Alan Donaldson, Christiana Kartsonaki, Carole Brewer, Matti A. Rookus, Jacek Gronwald, Dorothea Gadzicki, Shirley Hodgson, Jonathan Beesley, Gabriella Pichert, Andrew K. Godwin, Dieter Niederacher, Yuan Chun Ding, Torben A Kruse, Paolo Peterlongo, Rita K. Schmutzler, Xiaoqing Chen, Annika Lindblom, Fergus J. Couch, Maaike P.G. Vreeswijk, Mark H. Greene, Esther M. John, Raymonda Varon-Mateeva, Simon A. Gayther, Margreet G. E. M. Ausems, Tomas Kirchhoff, Lars Jønson, Madeleine M. A. Tilanus-Linthorst, Ute Hamann, Marie-Agnès Collonge-Rame, Antonis C. Antoniou, M John Kennedy, Karin Kast, Theo A. M. van Os, Penny Soucy, Debra Frost, Alison M. Dunning, Daniela Zaffaroni, Anna Allavena, Maria-Isabel Tejada, Yves-Jean Bignon, Lesley McGuffog, Bohdan Górski, Åke Borg, Fabienne Prieur, Bernard Peissel, Helen Gregory, Clare Oliver, Saundra S. Buys, Ana Dutra-Clarke, Alfons Meindl, Ramunas Janavicius, Uffe Birk Jensen, Miguel de la Hoya

المساهمون: Ramus, S, Kartsonaki, C, Gayther, S, Pharoah, P, Sinilnikova, O, Beesley, J, Chen, X, Mcguffog, L, Healey, S, Couch, F, Wang, X, Fredericksen, Z, Peterlongo, P, Manoukian, S, Peissel, B, Zaffaroni, D, Roversi, G, Barile, M, Viel, A, Allavena, A, Ottini, L, Papi, L, Gismondi, V, Capra, F, Radice, P, Greene, M, Mai, P, Andrulis, I, Glendon, G, Ozcelik, H, Thomassen, M, Gerdes, A, Kruse, T, Cruger, D, Jensen, U, Caligo, M, Olsson, H, Kristoffersson, U, Lindblom, A, Arver, B, Karlsson, P, Stenmark Askmalm, M, Borg, A, Neuhausen, S, Ding, Y, Nathanson, K, Domchek, S, Jakubowska, A, Lubiński, J, Huzarski, T, Byrski, T, Gronwald, J, Górski, B, Cybulski, C, Dębniak, T, Osorio, A, Durán, M, Tejada, M, Benítez, J, Hamann, U, Rookus, M, Verhoef, S, Tilanus Linthorst, M, Vreeswijk, M, Bodmer, D, Ausems, M, van Os, T, Asperen, C, Blok, M, Meijers Heijboer, H, Peock, S, Cook, M, Oliver, C, Frost, D, Dunning, A, Evans, D, Eeles, R, Pichert, G, Cole, T, Hodgson, S, Brewer, C, Morrison, P, Porteous, M, Kennedy, M, Rogers, M, Side, L, Donaldson, A, Gregory, H, Godwin, A, Stoppa Lyonnet, D, Moncoutier, V, Castera, L, Mazoyer, S, Barjhoux, L, Bonadona, V, Leroux, D, Faivre, L, Lidereau, R, Nogues, C, Bignon, Y, Prieur, F, Collonge Rame, M, Venat Bouvet, L, Fert Ferrer, S, Miron, A, Buys, S, Hopper, J, Daly, M, John, E, Terry, M, Goldgar, D, Hansen, T, Jønson, L, Ejlertsen, B, Agnarsson, B, Offit, K, Kirchhoff, T, Vijai, J, Dutra Clarke, A, Przybylo, J, Montagna, M, Casella, C, Imyanitov, E, Janavicius, R, Blanco, I, Lázaro, C, Moysich, K, Karlan, B, Gross, J, Beattie, M, Schmutzler, R, Wappenschmidt, B, Meindl, A, Ruehl, I, Fiebig, B, Sutter, C, Arnold, N, Deissler, H, Varon Mateeva, R, Kast, K, Niederacher, D, Gadzicki, D, Caldes, T, de la Hoya, M, Nevanlinna, H, Aittomäki, K, Simard, J, Soucy, P, Spurdle, A, Holland, H, Chenevix Trench, G, Easton, D, Antoniou, A, Faculteit Medische Wetenschappen/UMCG, Biostatistiques santé, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Klinische Genetica, Genetica & Celbiologie, RS: GROW - School for Oncology and Reproduction, Clinical Genetics, Pediatric Surgery, Human genetics, CCA - Oncogenesis, Human Genetics

المصدر: JOURNAL OF THE NATIONAL CANCER INSTITUTE, 103(2), 105-116. Oxford University Press
Ramus, S J, Kartsonaki, C, Gayther, S A, Pharoah, P D P, Sinilnikova, O M, Beesley, J, Chen, X Q, McGuffog, L, Healey, S, Couch, F J, Wang, X S, Fredericksen, Z, Peterlongo, P, Manoukian, S, Peissel, B, Zaffaroni, D, Roversi, G, Barile, M, Viel, A, Allavena, A, Ottini, L, Papi, L, Gismondi, V, Capra, F, Radice, P, Greene, M H, Mai, P L, Andrulis, I L, Glendon, G, Ozcelik, H, Thomassen, M, Gerdes, A M, Kruse, T A, Cruger, D, Jensen, U B, Caligo, M A, Olsson, H, Kristoffersson, U, Lindblom, A, Arver, B, Karlsson, P, Askmalm, M S, Borg, A, Neuhausen, S L, Ding, Y C, Nathanson, K L, Domchek, S M, Jakubowska, A, Lubinski, J, Huzarski, T, Byrski, T, Gronwald, J, Gorski, B, Cybulski, C, Debniak, T, Osorio, A, Duran, M, Tejada, M I, Benitez, J, Hamann, U, Rookus, M A, Verhoef, S, Tilanus-Linthorst, M A, Vreeswijk, M P, Bodmer, D, Ausems, M G E M, Os, T A, van Asperen, C J, Blok, M J, Meijers-Heijboer, E J, Peock, S, Cook, M, Oliver, C, Frost, D, Dunning, A M, Evans, D G, Eeles, R, Pichert, G, Cole, T, Hodgson, S, Brewer, C, Morrison, P J, Porteous, M, Kennedy, M J, Rogers, M T, Side, L E, Donaldson, A, Gregory, H, Godwin, A, Stoppa-Lyonnet, D, Moncoutier, V, Castera, L, Mazoyer, S, Barjhoux, L, Bonadona, V, Leroux, D, Faivre, L, Lidereau, R & Nogues, C 2011, ' Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers ', Journal of the National Cancer Institute, vol. 103, no. 2, pp. 105-116 . https://doi.org/10.1093/jnci/djq494
Ramus, S J, Kartsonaki, C, Gayther, S A, Pharoah, P D P, Sinilnikova, O M, Beesley, J, Chen, X, McGuffog, L, Healey, S, Couch, F J, Wang, X, Fredericksen, Z, Peterlongo, P, Manoukian, S, Peissel, B, Zaffaroni, D, Roversi, G, Barile, M, Viel, A, Allavena, A, Ottini, L, Papi, L, Gismondi, V, Capra, F, Radice, P, Greene, M H, Mai, P L, Andrulis, I L, Glendon, G, Ozcelik, H, Thomassen, M, Gerdes, A-M A, Kruse, T A, Cruger, D, Jensen, U B, Caligo, M A, Olsson, H, Kristoffersson, U, Lindblom, A, Arver, B, Karlsson, P W, Stenmark Askmalm, M, Borg, A, Neuhausen, S L, Ding, Y C, Nathanson, K L, Frost, D, Hansen, T V O, Holland, H & OCGN 2011, ' Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers ', Journal of the National Cancer Institute, vol. 103, no. 2, pp. 105-16 . https://doi.org/10.1093/jnci/djq494
University of Manchester-PURE
Journal of the National Cancer Institute
Journal of the National Cancer Institute, 2011, 103, pp.1-13
Journal of the National Cancer Institute, 103(2). Oxford University Press
JNCI: Journal of the National Cancer Institute
JNCI: Journal of the National Cancer Institute, 2011, 103, pp.1-13. ⟨10.1093/jnci/djq494⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
Ramus, S J, Kartsonaki, C, Gayther, S A, Pharoah, P D P, Sinilnikova, O M, Beesley, J, Chen, X, McGuffog, L, Healey, S, Couch, F J, Wang, X, Fredericksen, Z, Peterlongo, P, Manoukian, S, Peissel, B, Zaffaroni, D, Roversi, G, Barile, M, Viel, A, Allavena, A, Ottini, L, Papi, L, Gismondi, V, Capra, F, Radice, P, Greene, M H, Mai, P L, Andrulis, I L, Glendon, G, Ozcelik, H, Thomassen, M, Gerdes, A-M, Kruse, T A, Cruger, D, Jensen, U B, Caligo, M A, Olsson, H, Kristoffersson, U, Lindblom, A, Arver, B, Karlsson, P, Stenmark Askmalm, M, Borg, A, Neuhausen, S L, Ding, Y C, Nathanson, K L, Domchek, S M, Jakubowska, A, Lubinski, J, Huzarski, T & OCGN 2011, ' Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers ', National Cancer Institute. Journal
, vol. 103, no. 2, pp. 105-116 . https://doi.org/10.1093/jnci/djq494
Journal of the National Cancer Institute, 103(2), 105-116. Oxford University Press

مصطلحات موضوعية: Oncology, Cancer Research, endocrine system diseases, Genes, BRCA2, Genes, BRCA1, Genome-wide association study, FAMILIES, 0302 clinical medicine, Risk Factors, Retrospective Studie, Genotype, Odds Ratio, skin and connective tissue diseases, POPULATION, Genetics, Ovarian Neoplasms, Aged, 80 and over, Allele, 0303 health sciences, education.field_of_study, Likelihood Functions, Articles, GERMLINE MUTATIONS, Middle Aged, Likelihood Function, female genital diseases and pregnancy complications, 3. Good health, 030220 oncology & carcinogenesis, Female, Chromosomes, Human, Pair 9, Human, Adult, [SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT], medicine.medical_specialty, Heterozygote, SUSCEPTIBILITY LOCI, PROTEINS, Population, Biology, Polymorphism, Single Nucleotide, BASONUCLIN-2, 03 medical and health sciences, Breast cancer, Germline mutation, SDG 3 - Good Health and Well-being, Internal medicine, medicine, BREAST-CANCER, Humans, GENOME-WIDE ASSOCIATION, education, Alleles, Germ-Line Mutation, 030304 developmental biology, Retrospective Studies, Aged, IDENTIFICATION, Risk Factor, Ovarian Neoplasm, Editorials, Cancer, medicine.disease, Minor allele frequency, Ovarian cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cf6585e461a42f7e37cbee4d0997795
http://hdl.handle.net/10281/28431